Tag: Fast Track Designation

October 7, 2019

Mereo BioPharma Receives Fast Track Designation for Navicixizumab

The company received fast track designation from the US Food and Drug Administration for its treatment navicixizumab.
August 21, 2019

Cerecor Receives Fast Track Designation from FDA for CERC-802

Cerecor (NASDAQ:CERC) has announced that the US Food and Drug Administration has granted the company fast track designation for CERC-802...
June 18, 2019

Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy

Abeona Therapeutics (NASDAQ:ABEO) has announced that the US Food and Drug Administration (FDA) has granted the company fast track designation...
May 14, 2019

Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate

Homology Medicines (NASDAQ:FIXX) has announced that the US Food and Drug Administration (FDA) has given it Fast Track designation for...
May 6, 2019

Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™

Zynerba Pharmaceuticals (NASDAQ:ZYNE) has announced that the US Food and Drug Administration (FDA) has given fast track designation for the...
February 19, 2019

Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency

Cerecor (NASDAQ:CERC) has announced that the US Food and Drug Administration (FDA) has designated fast track designation for CERC-901, an...
December 19, 2018

Equillium Granted U.S. FDA Fast Track Designation for EQ001

Equillium (Nasdaq:EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the U.S. Food and Drug Administration...